Safety and Pharmacokinetics of LPX-TI641 in Rheumatoid Arthritis and Psoriatic Arthritis

Clinical trial NCT06628206 · RECRUITING

Trial details

NCT number: NCT06628206
Sponsor: LAPIX Therapeutics Inc.
Status: RECRUITING
Phase: Phase 1
Study type: INTERVENTIONAL

Rheumatoid Arthritis (RA)Psoriatic Arthritis (PsA)

Start date: 2024-12-15
Primary completion: 2025-12-15
Enrollment: 48

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.